Compelling reports have demonstrated that IDO promoted the IL-6 expression in tumor cells [24–26], and in turn, IL-6 was reported to upregulate IDO expression through a JAK/STAT signaling pathway [27, 28]. The gene discussed is IL6; the disease is neoplasm.